| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Fabad Journal of Pharmaceutical Sciences |
2026―Mar―31 |
Dornase Alfa as a Potential Treatment Option for SARS-CoV-2: In Vitro Insights |
Derya Dilek Kançağı, Cihan Taştan, Kevser Buse Karadeniz, Selen Abanuz, Didem Çakırsoy Akyöney, Yaren Büyükçolak, et al. (+6) Sezer Akyoney, Gözde Karakus, Bulut Yurtsever, Koray Yalçın, İsmail Tuncer Değim, Ercüment Ovalı |
| 2 |
[GO] |
Fabad Journal of Pharmaceutical Sciences |
2026―Mar―31 |
Evaluation for Dissolution Profile Similarity of Multisource Generic Products Containing Favipiravir in the Treatment of COVID-19: Model-independent Bootstrap f2 and Model-dependent Approaches |
Duygu Yılmaz Usta |
| 3 |
[GO] |
Fabad Journal of Pharmaceutical Sciences |
2026―Mar―31 |
Medicinal Chemistry Approaches for Combatting SARS-CoV-2 and COVID-19 Therapeutics |
Neelottama Kushwaha, Swatantra Kushwaha, Anmol Kumar |
| 4 |
[GO] |
Fabad Journal of Pharmaceutical Sciences |
2025―Nov―21 |
The New Generation E-Cigarette Pandemic Threatening Youth: Puff Bars |
İsmet Çok, Pınar Uğurlu |
| 5 |
[GO] |
Fabad Journal of Pharmaceutical Sciences |
2024―Aug―19 |
A qualitative study exploring self-management behaviour of patients with chronic kidney disease during COVID-19 |
Mehmet Barlas Uzun, Gizem Gülpınar, Aysel Pehkivanlı, Şule Şengül |
| 6 |
[GO] |
Fabad Journal of Pharmaceutical Sciences |
2024―Mar―25 |
Financial Development of the Turkish Pharmaceutical Sector During and After the Pandemic: Sector Panel Data Analysis for the Period 2018-2022 |
Mustafa ÖZYEŞİL, Havane TEMBELO |
